Biogen BIIB Reportable Segment — Net income attributable to Biogen Inc.
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biogen's reportable segment — net income attributable to biogen inc..
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biogen's reportable segment — net income attributable to biogen inc.?
- Biogen (BIIB) reported reportable segment — net income attributable to biogen inc. of $319.5M in Q1 2026.
- How has Biogen's reportable segment — net income attributable to biogen inc. changed year-over-year?
- Biogen's reportable segment — net income attributable to biogen inc. increased by 32.8% year-over-year, from $240.5M to $319.5M.
- What is the long-term trend for Biogen's reportable segment — net income attributable to biogen inc.?
- Over 3 years (2022 to 2025), Biogen's reportable segment — net income attributable to biogen inc. has grown at a -23.9% compound annual growth rate (CAGR), from $3.05B to $1.34B.
- What does reportable segment — net income attributable to biogen inc. mean?
- This represents the residual profit of the business segment after accounting for all operating expenses, taxes, and non-controlling interests. It is the definitive measure of the segment's financial health and its contribution to the parent company's overall earnings. This metric is critical for evaluating the segment's ability to generate sustainable value for shareholders.